Known targets — ChEMBL curated mechanism
ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 6/20 | 0.46 |
| ▸ | CA2 | P00918 | 6/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL717926 | 0.91 | LMNA (0.68) | LMNACYP1A2CYP2C9MAPTALDH1A1 | |
| SCHEMBL18281078 | 0.91 | LMNA (0.68) | LMNACYP1A2CYP2C9MAPTALDH1A1 | |
| SCHEMBL1177430 | 0.89 | LMNA (0.62) | LMNACYP1A2CYP2C9MAPTALDH1A1 | |
| SCHEMBL31657625 | 0.88 | LMNA (0.61) | LMNAMAPTALDH1A1GAACA1 | |
| SCHEMBL8508557 | 0.88 | ALDH1A1 (0.64) | LMNACYP1A2CYP2C9MAPTALDH1A1 | |
| SCHEMBL1363911 | 0.87 | LMNA (0.64) | LMNACYP1A2CYP2C9MAPTALDH1A1 | |
| SCHEMBL4447797 | 0.87 | LMNA (0.54) | LMNACYP1A2CYP2C9MAPTALDH1A1 | |
| SCHEMBL1365851 | 0.86 | LMNA (0.62) | LMNACYP1A2CYP2C9MAPTALDH1A1 | |
| Toluene SCHEMBL27392908 | 0.85 | ALDH1A1 (0.58) | LMNAMAPTALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL1365332 | 0.85 | LMNA (0.61) | LMNACYP1A2CYP2C9MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062378-A1 | O-TERT-BUTYL-L-SERYL-O-TERT-BUTYL-L-SERYL-GLYCINE AND PREPARATION METHOD THEREOF | SICHUAN SHIFANG SANGAO BIOCHEMICAL INDUSTRIAL CO., LTD. (CN) | 2026-03-05 | — | — | US | claimed |
| CN-222263523-U | Perovskite solar cell | 旗滨新能源发展(深圳)有限责任公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119080874-A | O-tert-butyl-L-seryl-glycine and preparation method thereof | 四川什邡市三高生化实业有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-115746213-B | Anti-fouling resin and preparation method thereof | 深圳市通泰盈科技股份有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-117552007-A | Preparation method of water-based corrosion inhibitor for aviation | 成都佳驰电子科技股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-115746213-A | Anti-fouling resin and preparation method thereof | 深圳市通泰盈科技股份有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-112300245-B | RGDS and theanine co-modified 5-fluorouracil, and synthesis, activity and application thereof | 首都医科大学（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-110283109-B | Method for industrially preparing racecadotril | 陕西汉江药业集团股份有限公司 | 2021-01-08 | — | — | CN | claimed |
| CN-109438303-B | Method for preparing racecadotril by one-pot method | 山东齐都药业有限公司 | 2020-10-16 | — | — | CN | claimed |
| CN-109942468-B | Process method for preparing cadotril from 3-phenyl-1-propyne | 大连万福制药有限公司 | 2020-09-29 | — | — | CN | claimed |
| CN-105503665-A | Preparation method of glycine benzyl ester toluene-4-sulfonate | SHANDONG BOYUAN PHARMACEUTICAL CO LTD | 2016-04-20 | — | — | CN | claimed |
| CN-105477691-A | Preparation method of chitosan composited N-diphenylmethylene-amino-glycine benzyl ester anticoagulant material | MEI QINGBO | 2016-04-13 | — | — | CN | claimed |
| CN-103044523-B | Dexamethasone-RGD polypeptide conjugate, preparation method thereof and application | JINAN XIANGHUI PHARMACEUTICAL TECHNOLOGY CO LTD | 2014-05-21 | — | — | CN | claimed |
| CN-103755611-A | Preparation method of racecadotril | SHAANXI HANJIANG PHARMACEUTICAL CROUP CO LTD | 2014-04-30 | — | — | CN | claimed |
| CN-103012553-B | Cortisone-RGD polypeptide conjugate, and preparation method and application thereof | JINAN XIANGHUI MEDICAL TECHNOLOGY CO LTD | 2014-04-16 | — | — | CN | claimed |
| CN-102317256-B | Method for preparing racecadotril | BEIJING MEDIKING BIOPHARM CO LTD | 2013-12-11 | — | — | CN | claimed |
| CN-103044523-A | Dexamethasone-RGD polypeptide conjugate, preparation method thereof and application | JINAN XIANGHUI PHARMACEUTICAL TECHNOLOGY CO LTD | 2013-04-17 | — | — | CN | claimed |
| CN-103012553-A | Cortisone-RGD polypeptide conjugate, and preparation method and application thereof | JINAN XIANGHUI MEDICAL TECHNOLOGY CO LTD | 2013-04-03 | — | — | CN | claimed |
| CN-103012554-A | Hydrocortisone-RGD polypeptide conjugate, and preparation method and application thereof | SHANDONG BAYONN PHARMACEUTICAL TECHNOLOGY CO LTD | 2013-04-03 | — | — | CN | claimed |
| CN-101768095-A | Preparation method of racecadotril | SHANDONG QIDU PHARMACEUTICAL C | 2010-07-07 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062378-A1 | O-TERT-BUTYL-L-SERYL-O-TERT-BUTYL-L-SERYL-GLYCINE AND PREPARATION METHOD THEREOF | MGMT, TERT, SPTSSB | LMNA 372/4885CYP1A2 3467/4885CYP2C9 2883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.